Recombinant Zoster Vaccine Uptake and Risk of Flares Among Older Adults With Immune-Mediated Inflammatory Diseases in the US.
Jessica W LeungTara C AndersonKathleen DoolingFenglong XieJeffrey R CurtisPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2022)
We did not find an increase in presumed flares following RZV vaccination. Among adults ages ≥50 years with IMIDs, a substantial proportion received RZV compared to general zoster coverage estimates, and series completion rates were high.
Keyphrases